Leo Pharma A/S has invited investment bankers to vie for roles in a potential initial public offering, according to people familiar with the matter, as the more-than-a-century-old Danish drugmaker edges closer to going public.
The company, which focuses on skin conditions, is considering Copenhagen as a possible listing venue, said the people, who asked not to be identified as the information is private. Deliberations are ongoing and no final decisions have been made, the people said.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.